Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03870971 · ClinicalTrials.gov registry record · NA
User Evaluation of the Invasive Component of the CNOGA TensorTip COMBO GLUCOMETER (CoG)
A NA study of Diabetes Mellitus, sponsored by Sciema UG.
- Completed
- Registry status
- NA
- Development phase
- 543
- Enrollment target
- 1
- Study location
NCT03870971: Completed NA study of Diabetes Mellitus, sponsored by Sciema UG.
NCT03870971 is a NA study of Diabetes Mellitus that has completed, run by Sciema UG. The registered enrollment target is 543 participants, below the 1,865-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03870971, a NA study of Diabetes Mellitus, has completed, sponsored by Sciema UG.
- COMPLETED
- Registry status
- NA
- Development phase
- 543 participants
- Enrollment target
- 1
- Study location
Study Summary
Open label, prospective, comparative, multi-center study. All participants will get an introduction to the invasive component of the TENSORTIP COG by means of the instructions for use in English language only (incl. an illustrated short manual) and will be asked to perform a reading without further device training. Thereafter, a healthcare professional will perform an additional reading with the reference method (YSI 2300 STAT plus). In addition, blood will be drawn for determination of hematocrit. In the study, a minimum of 10 test strip vials that cover a minimum of 3 strip lots will be used. In addition multiple devices will be employed. After completion of the study the study participants will be given a questionnaire to fill out.
Primary Outcome
invasive CoG (study device) blood glucose measurement in comparison to blood glucose measurment of a comparator device (YSI 2300 STAT Plus).
Conditions Studied
Interventions
- OTHER blood glucose measurement
Study Locations (1)
Washington
- Rainier Clinical Research Center, Inc. - Renton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 543 participants |
| Start Date | 2019-02-04 |
| Est. Completion | 2019-08-31 |
| Phase | NA |
What the finished NCT03870971 record still lists
NCT03870971 is an interventional study that assigns participants to a tested intervention. The registered 543 participants enrollment target is mid-sized for trials with a published cap, below the 1,865-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (71% lower).
The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which blood glucose measurement is the first listed.
NCT03870971 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT03870971 about?
NCT03870971 is a clinical study titled "User Evaluation of the Invasive Component of the CNOGA TensorTip COMBO GLUCOMETER (CoG)". Open label, prospective, comparative, multi-center study. All participants will get an introduction to the invasive component of the TENSORTIP COG by means of the instructions for use in English language only (incl. an illustrated short manual) and will be asked to perform a reading without further ...
What is the current status of trial NCT03870971?
This trial is currently completed. It is a NA study. The enrollment target is 543 participants. The study started on 2019-02-04. Estimated completion is 2019-08-31.
What conditions does trial NCT03870971 study?
This clinical trial studies the following conditions: Diabetes Mellitus.
What interventions are being tested in trial NCT03870971?
The interventions under investigation include: blood glucose measurement (OTHER).
Who is sponsoring clinical trial NCT03870971?
This trial is sponsored by Sciema UG, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03870971 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03870971's enrollment target sits among peer trials
543 44th of 208 higher than 165 of 208 other Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07294053 · 543 participants · NA
Sugary Drink Labeling Study
- NCT03127761 · 544 participants
Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma
- NCT04378790 · 544 participants · Phase 3
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
- NCT06118502 · 544 participants · NA
A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI